Search Results

Showing results 1081 - 1090 for leonard

The role of transplant in mantle cell lymphoma | Sandra and Edward Meyer Cancer Center

...Novel agents improve MCL care, tumor profiling key to further advances Leonard reflects on progress for...

https://meyercancer.weill.cornell.edu/news/2017-05-22/role-transplant-mantle-cell-lymphoma

Center for Health Economics of Treatment for Substance Users Established | Newsroom | Weill Cornell Medicine

...Daniel Polsky, the executive director of the Leonard Davis Institute of Health Economics at the University...

https://news.weill.cornell.edu/news/2015/08/center-for-health-economics-of-treatment-for-substance-users-established

A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma. | Pathology & Laboratory Medicine

...Maddocks K, Ruan J, Ridling LA, Dittus C, Chen Z, Huang X, Inghirami G, Diliberto M, Chen-Kiang S, Leonard...

https://pathology.weill.cornell.edu/research/publications/phase-1-trial-ibrutinib-plus-palbociclib-previously-treated-mantle-cell

Outcome of deferred initial therapy in mantle-cell lymphoma. | Pathology & Laboratory Medicine

...Ruan J, Elstrom R, Niesvizky R, Ely S, Diliberto M, Melnick A, Knowles DM, Chen-Kiang S, Coleman M, Leonard...

https://pathology.weill.cornell.edu/research/publications/outcome-deferred-initial-therapy-mantle-cell-lymphoma

Postibrutinib outcomes in patients with mantle cell lymphoma. | Pathology & Laboratory Medicine

...Publication Type Journal Article Year of Publication 2016 Authors Martin P, Maddocks K, Leonard JP,...

https://pathology.weill.cornell.edu/research/publications/postibrutinib-outcomes-patients-mantle-cell-lymphoma

Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCL. | Cerchietti Research Lab

...Chavez JC, Reagan JL, Smith SM, LaCasce AS, Jones J, Drew J, Wu C, Mulvey E, Revuelta MV, Cerchietti L, Leonard...

https://cerchiettilab.weill.cornell.edu/publications/phase-1-study-oral-azacitidine-cc-486-plus-r-chop-previously-untreated-intermediate

What Inspires Giving? | Giving to Weill Cornell Medicine

...Kanas John Leonard, MD Daisy M....

https://give.weill.cornell.edu/milestones/what-inspires-giving

News | Newsroom | Weill Cornell Medicine

...Leonard Girardi, Dr....

https://news.weill.cornell.edu/news?page=37

Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R. | Roth Lab

...Dave H, Gardner R, Stephens DM, Zeitler WA, Forlenza C, Levine J, Williams ME, Sima JL, Bollard CM, Leonard...

https://rothlab.weill.cornell.edu/publications/outcomes-adults-and-children-primary-mediastinal-b-cell-lymphoma-treated-dose-adjusted

Dr. Greenfield to Lead Residency Program | Neurological Surgery

...attending neurological surgeon at Och Spine at NewYork-Presbyterian/Weill Cornell Medical Center and the Leonard...

https://neurosurgery.weill.cornell.edu/about-us/news-updates/dr-greenfield-lead-residency-program

Showing results 1081 - 1090 for leonard